Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform recommendation. As of February 19, 2025, the average one-year price ...
William Blair started coverage on shares of Structure Therapeutics (NASDAQ:GPCR – Free Report) in a research note published on Friday, Marketbeat Ratings reports. The brokerage issued an ...
Research analysts at William Blair initiated coverage on shares of Immunic (NASDAQ:IMUX – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The ...
Investing.com -- William Blair upgraded Palantir Technologies ... payment tracking systems to assist with cost-cutting initiatives and the Department of Defense’s annual audit, which it has ...
Hosted on MSN4mon
Cargo Therapeutics draws bullish view at William Blair on lead assetCell therapy developer CARGO Therapeutics (NASDAQ:CRGX) traded higher on Tuesday after William Blair launched its coverage with ... “We believe near-term initiatives to expand CAR-T access ...
On Monday, William Blair reaffirmed a Market Perform rating ... sequential sales growth throughout the year. The company's initiatives, if successful, may set Kenvue on a course to reach its ...
Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (LSE:0A4C) with a Market Perform recommendation. There are 326 funds or institutions reporting positions in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback